AlphaSense Alternative
Why do former AlphaSense customers love DealForma?Finally, a deals database built specifically for biopharma.
DealForma stands out as the best in biopharma deal data with its comprehensive coverage of biotech and pharma licensing and funding transactions by providing a superior experience when it comes to deal terms. We focus on delivering high-quality deal data so you can have confidence that you are getting complete and accurate information for your biopharma business development deal comps and benchmark research.
Comprehensive Coverage
In-Depth Analytics
With granular and relevant filters, DealForma allows you to delve into transaction details, track trends, and gain valuable insights into deal structures, valuations, therapeutic areas, and key players, enabling strategic planning, market analysis, and competitive intelligence.
Advanced Deal Monitoring
Business developers are switching to DealForma for its advanced deal monitoring capabilities. The platform enables you to set up alerts for specific criteria, such as target companies, indications, or modalities so you stay informed about the latest developments and deal opportunities.
Compare DealForma vs. AlphaSense
Comparison based on customer feedback and public information gathered June 2023 to the best of our knowledge. We understand the world is constantly changing, so if you see we missed a feature or made a mistake, let us know.
DealForma vs. AlphaSense
AlphaSense specializes in Wall St. analyst reports and earnings call transcripts, providing valuable financial insights. DealForma excels in deal comps, upfronts, milestones, R&D, profit splits, deal structures, and asset stages, offering you analyst-curated and comprehensive data on biopharma deals.
Why are biopharma and finance companies switching to DealForma?
"DealForma is a Better Deal Database"
Intuitive, Modern Interface
Intentional Biopharma Deal Curation
Analysts at DealForma have experience reading thousands of deal and funding announcements and company filings. Teams assigned to each segment look for key terms to separate out from a noisy news flow. And they do this manually, every day, so you can quickly filter through decades of carefully curated, relevant transaction profiles.
Included Analyst Support




21,135
Licensing Deals
4,145
M&A
5,766
Other Deals
21,479
Funding Rounds
34,717
Company Profiles
26,805
Drug Sales Figures
All of this by stage, disease indication, modality, target...